MYGN
Myriad Genetics Inc
NASDAQ: MYGN · HEALTHCARE · DIAGNOSTICS & RESEARCH
$4.11
-18.29% today
Updated 2026-05-06
Market cap
$475.05M
P/E ratio
—
P/S ratio
0.85x
EPS (TTM)
$-4.31
Dividend yield
—
52W range
$4 – $9
Volume
1.9M
Myriad Genetics Inc (MYGN) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
6 of 8
Last 8 quarters
Avg EPS surprise
—
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
+100.0%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-4.6%
Last 3 reports
Positive reaction rate
67%
2 of 3 quarters
Largest single-day move
-19.7%
2025-11-03
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-04-30 | $0.00 | +100.0% | $4.68 | $4.80 | +2.6% |
| 2026-02-23 | $0.04 | +332.6% | $4.29 | $4.43 | +3.3% |
| 2025-11-03 | $-0.29 | -2843.0% | $8.04 | $6.46 | -19.7% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2026-03-31 | $-0.00 | $0.00 | +100.0% | — | — |
| 2025-12-31 | $-0.02 | $0.04 | +332.6% | $209.80M | -0.4% |
| 2025-09-30 | $-0.01 | $-0.29 | -2843.0% | $205.70M | -3.6% |
| 2025-06-30 | $-0.01 | $0.05 | +600.0% | $213.10M | +0.8% |
| 2025-03-31 | $-0.05 | $-0.03 | +44.9% | $195.90M | -3.1% |
| 2024-12-31 | $0.03 | $0.03 | -1.0% | $210.60M | +7.1% |
| 2024-09-30 | $0.02 | $0.06 | +200.0% | $213.30M | +11.2% |
| 2024-06-30 | $-0.01 | $0.05 | +600.0% | $211.50M | +15.3% |
| 2024-03-31 | $-0.10 | $-0.01 | +90.0% | $202.20M | — |
| 2023-12-31 | $0.01 | $0.04 | +300.0% | $196.60M | — |
| 2023-09-30 | $-0.08 | $-0.03 | +62.5% | $191.90M | — |
| 2023-06-30 | $-0.08 | $-0.08 | +0.0% | $183.50M | — |
Frequently asked questions
Has Myriad Genetics Inc beaten earnings estimates?
Myriad Genetics Inc has beaten Wall Street EPS estimates in 6 of its last 8 quarterly reports.
How does MYGN stock react to earnings?
MYGN stock has moved an average of -4.6% in the trading day following earnings over its last 3 reports, with positive reactions in 67% of those quarters.